145 related articles for article (PubMed ID: 22994740)
21. GOLPH3 promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma via mTOR and Wnt/β‑catenin signal activation.
Wang JH; Yuan LJ; Liang RX; Liu ZG; Li BH; Wen ZS; Huang ST; Zheng M
Mol Med Rep; 2017 Nov; 16(5):7138-7144. PubMed ID: 28901498
[TBL] [Abstract][Full Text] [Related]
22. miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21.
Zheng R; Liu Y; Zhang X; Zhao P; Deng Q
Biomed Pharmacother; 2017 Jun; 90():517-523. PubMed ID: 28402920
[TBL] [Abstract][Full Text] [Related]
23. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
24. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
25. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
26. Down-regulating ATDC inhibits the proliferation of esophageal carcinoma cells.
Lai W; Zheng X; Huang Q; Wu X; Yang M
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3511-6. PubMed ID: 25491629
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
28. The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma.
Shimizu H; Shiozaki A; Ichikawa D; Fujiwara H; Konishi H; Ishii H; Komatsu S; Kubota T; Okamoto K; Kishimoto M; Otsuji E
J Gastroenterol; 2014 Apr; 49(4):655-66. PubMed ID: 23657608
[TBL] [Abstract][Full Text] [Related]
29. Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells.
Zhao L; Wei ZB; Yang CQ; Chen JJ; Li D; Ji AF; Ma L
Asian Pac J Cancer Prev; 2014; 15(13):5437-42. PubMed ID: 25041015
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer.
Zhang H; Zhao JH; Suo ZM
Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137
[TBL] [Abstract][Full Text] [Related]
31. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
33. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
Bai G; Chu J; Eli M; Bao Y; Wen H
Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
[TBL] [Abstract][Full Text] [Related]
34. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
35. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
36. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
37. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
38. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
[TBL] [Abstract][Full Text] [Related]
39. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
[TBL] [Abstract][Full Text] [Related]
40. The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via β-catenin-dependent signaling.
Wang L; Lu A; Liu X; Sang M; Shan B; Meng F; Cao Q; Ji X
Oncol Rep; 2011 Nov; 26(5):1149-56. PubMed ID: 21785828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]